{"id":2821,"date":"2024-04-17T17:17:24","date_gmt":"2024-04-17T17:17:24","guid":{"rendered":"https:\/\/mmevost.wpenginepowered.com\/success-stories\/novelrad-nvcd\/"},"modified":"2025-11-25T14:07:19","modified_gmt":"2025-11-25T14:07:19","slug":"novelrad-nvcd","status":"publish","type":"success-stories","link":"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/novelrad-nvcd\/","title":{"rendered":"Novelrad \u2013 NVCD"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"<p>Novelrad, ganadora del EIC Accelerator, est\u00e1 creando un dispositivo de cierre de gran calibre que reduce las complicaciones sanitarias, recorta costes y salva vidas.<br \/>\nEIC Accelerator &#8211; 2,5 millones de euros<br \/>\nTipo de financiaci\u00f3n: Grant First<\/p>\n","protected":false},"featured_media":2458,"template":"","meta":{"_acf_changed":false},"flags":[96],"program":[46],"sector":[36],"class_list":["post-2821","success-stories","type-success-stories","status-publish","has-post-thumbnail","hentry","flags-il","program-instrumento-pyme-eic-accelerator","sector-salud"],"acf":{"layouts_cases":[{"acf_fc_layout":"content","content":{"sections_settings":{"section_id":"","section_background":false,"section_padding":"base"},"content":"Se prev\u00e9 que los procedimientos card\u00edacos y vasculares m\u00ednimamente invasivos que requieren un acceso vascular de gran calibre aumenten significativamente en los pr\u00f3ximos a\u00f1os, potencialmente hasta 6 veces. Sin embargo, estos procedimientos est\u00e1n asociados intr\u00ednsecamente a complicaciones significativas relacionadas con el lugar de acceso al vaso sangu\u00edneo y su cierre seguro.\r\n\r\nLos dispositivos de cierre existentes han demostrado ser inadecuados, con tasas de complicaciones que se mantienen en un 22%. Estas complicaciones prolongan la estancia hospitalaria, aumentan los costes sanitarios y elevan las tasas de morbilidad y mortalidad.\r\n\r\nReconociendo la persistente necesidad no cubierta de dispositivos de cierre de gran calibre rentables y fiables, <a href=\"https:\/\/novelrad.com\/\" target=\"_blank\" rel=\"noopener\">Novelrad<\/a> ha sido pionera en el desarrollo de la <strong>tecnolog\u00eda de microsutura<\/strong> que imita el trabajo de un cirujano vascular sin necesidad de realizar cirug\u00eda abierta. Con s\u00f3lo pulsar un bot\u00f3n, esta tecnolog\u00eda permite la colocaci\u00f3n m\u00ednimamente invasiva de un hilo de sutura alrededor del punto de acceso y ofrece una dilataci\u00f3n segura y un cierre fiable mediante un \u00fanico dispositivo, reduciendo as\u00ed significativamente las complicaciones y beneficiando tanto a los pacientes como a los sistemas sanitarios.\r\n\r\nLa revolucionaria tecnolog\u00eda de sutura transcat\u00e9ter de Novelrad permite abordar <strong>m\u00faltiples indicaciones en el sistema cardiovascular,<\/strong> y m\u00e1s all\u00e1, creando un enorme potencial de escalabilidad en diversos mercados.\r\n\r\nCon la primera subvenci\u00f3n del programa <a href=\"https:\/\/eic.ec.europa.eu\/eic-funding-opportunities\/eic-accelerator_en\" target=\"_blank\" rel=\"noopener\">,<\/a> Novelrad completar\u00e1 la validaci\u00f3n cl\u00ednica del dispositivo y obtendr\u00e1 el marcado CE para su comercializaci\u00f3n, adem\u00e1s de completar la fase de viabilidad para la primera indicaci\u00f3n intracard\u00edaca, por ejemplo, el cierre del agujero oval permeable. Estos avances beneficiar\u00e1n a los pacientes, sus familias y los sistemas sanitarios de toda Europa."}},{"acf_fc_layout":"media","media":{"sections_settings":{"section_id":"","section_background":false,"section_padding":"base"},"intro":"","section_type":"image","image":2456,"video_type":"mp4","upload_video":"","video_id":"","video_placeholder":"","video_title":"","button":null}}],"layouts":null},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.3 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Novelrad \u2013 NVCD - evolution-europe<\/title>\n<meta name=\"description\" content=\"Novelrad, ganadora del EIC Accelerator, est\u00e1 creando un dispositivo de cierre de gran calibre que reduce las complicaciones sanitarias, recorta costes y salva vidas. EIC Accelerator - 2,5 millones de euros Tipo de financiaci\u00f3n: Grant First\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/novelrad-nvcd\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novelrad \u2013 NVCD\" \/>\n<meta property=\"og:description\" content=\"Novelrad, ganadora del EIC Accelerator, est\u00e1 creando un dispositivo de cierre de gran calibre que reduce las complicaciones sanitarias, recorta costes y salva vidas. EIC Accelerator - 2,5 millones de euros Tipo de financiaci\u00f3n: Grant First\" \/>\n<meta property=\"og:url\" content=\"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/novelrad-nvcd\/\" \/>\n<meta property=\"og:site_name\" content=\"evolution-europe\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-25T14:07:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/evolutioneurope.eu\/wp-content\/uploads\/2025\/10\/Featured_Image_Novelrad.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"560\" \/>\n\t<meta property=\"og:image:height\" content=\"350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/casos-de-\u00e9xito\\\/novelrad-nvcd\\\/\",\"url\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/casos-de-\u00e9xito\\\/novelrad-nvcd\\\/\",\"name\":\"Novelrad \u2013 NVCD - evolution-europe\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/casos-de-\u00e9xito\\\/novelrad-nvcd\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/casos-de-\u00e9xito\\\/novelrad-nvcd\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/evolutioneurope.eu\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Featured_Image_Novelrad.jpg\",\"datePublished\":\"2024-04-17T17:17:24+00:00\",\"dateModified\":\"2025-11-25T14:07:19+00:00\",\"description\":\"Novelrad, ganadora del EIC Accelerator, est\u00e1 creando un dispositivo de cierre de gran calibre que reduce las complicaciones sanitarias, recorta costes y salva vidas. EIC Accelerator - 2,5 millones de euros Tipo de financiaci\u00f3n: Grant First\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/casos-de-\u00e9xito\\\/novelrad-nvcd\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/casos-de-\u00e9xito\\\/novelrad-nvcd\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/casos-de-\u00e9xito\\\/novelrad-nvcd\\\/#primaryimage\",\"url\":\"https:\\\/\\\/evolutioneurope.eu\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Featured_Image_Novelrad.jpg\",\"contentUrl\":\"https:\\\/\\\/evolutioneurope.eu\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Featured_Image_Novelrad.jpg\",\"width\":560,\"height\":350},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/casos-de-\u00e9xito\\\/novelrad-nvcd\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Success stories\",\"item\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/casos-de-\u00e9xito\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Novelrad \u2013 NVCD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/\",\"name\":\"evolution-europe\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/#organization\",\"name\":\"Evolution Europe\",\"url\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/evolutioneurope.eu\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/social-share-image-2000x1600-1.jpg\",\"contentUrl\":\"https:\\\/\\\/evolutioneurope.eu\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/social-share-image-2000x1600-1.jpg\",\"width\":2000,\"height\":1600,\"caption\":\"Evolution Europe\"},\"image\":{\"@id\":\"https:\\\/\\\/evolutioneurope.eu\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Novelrad \u2013 NVCD - evolution-europe","description":"Novelrad, ganadora del EIC Accelerator, est\u00e1 creando un dispositivo de cierre de gran calibre que reduce las complicaciones sanitarias, recorta costes y salva vidas. EIC Accelerator - 2,5 millones de euros Tipo de financiaci\u00f3n: Grant First","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/novelrad-nvcd\/","og_locale":"es_ES","og_type":"article","og_title":"Novelrad \u2013 NVCD","og_description":"Novelrad, ganadora del EIC Accelerator, est\u00e1 creando un dispositivo de cierre de gran calibre que reduce las complicaciones sanitarias, recorta costes y salva vidas. EIC Accelerator - 2,5 millones de euros Tipo de financiaci\u00f3n: Grant First","og_url":"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/novelrad-nvcd\/","og_site_name":"evolution-europe","article_modified_time":"2025-11-25T14:07:19+00:00","og_image":[{"width":560,"height":350,"url":"https:\/\/evolutioneurope.eu\/wp-content\/uploads\/2025\/10\/Featured_Image_Novelrad.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/novelrad-nvcd\/","url":"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/novelrad-nvcd\/","name":"Novelrad \u2013 NVCD - evolution-europe","isPartOf":{"@id":"https:\/\/evolutioneurope.eu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/novelrad-nvcd\/#primaryimage"},"image":{"@id":"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/novelrad-nvcd\/#primaryimage"},"thumbnailUrl":"https:\/\/evolutioneurope.eu\/wp-content\/uploads\/2025\/10\/Featured_Image_Novelrad.jpg","datePublished":"2024-04-17T17:17:24+00:00","dateModified":"2025-11-25T14:07:19+00:00","description":"Novelrad, ganadora del EIC Accelerator, est\u00e1 creando un dispositivo de cierre de gran calibre que reduce las complicaciones sanitarias, recorta costes y salva vidas. EIC Accelerator - 2,5 millones de euros Tipo de financiaci\u00f3n: Grant First","breadcrumb":{"@id":"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/novelrad-nvcd\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/novelrad-nvcd\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/novelrad-nvcd\/#primaryimage","url":"https:\/\/evolutioneurope.eu\/wp-content\/uploads\/2025\/10\/Featured_Image_Novelrad.jpg","contentUrl":"https:\/\/evolutioneurope.eu\/wp-content\/uploads\/2025\/10\/Featured_Image_Novelrad.jpg","width":560,"height":350},{"@type":"BreadcrumbList","@id":"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/novelrad-nvcd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/evolutioneurope.eu\/es\/"},{"@type":"ListItem","position":2,"name":"Success stories","item":"https:\/\/evolutioneurope.eu\/es\/casos-de-\u00e9xito\/"},{"@type":"ListItem","position":3,"name":"Novelrad \u2013 NVCD"}]},{"@type":"WebSite","@id":"https:\/\/evolutioneurope.eu\/es\/#website","url":"https:\/\/evolutioneurope.eu\/es\/","name":"evolution-europe","description":"","publisher":{"@id":"https:\/\/evolutioneurope.eu\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/evolutioneurope.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/evolutioneurope.eu\/es\/#organization","name":"Evolution Europe","url":"https:\/\/evolutioneurope.eu\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/evolutioneurope.eu\/es\/#\/schema\/logo\/image\/","url":"https:\/\/evolutioneurope.eu\/wp-content\/uploads\/2026\/04\/social-share-image-2000x1600-1.jpg","contentUrl":"https:\/\/evolutioneurope.eu\/wp-content\/uploads\/2026\/04\/social-share-image-2000x1600-1.jpg","width":2000,"height":1600,"caption":"Evolution Europe"},"image":{"@id":"https:\/\/evolutioneurope.eu\/es\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/evolutioneurope.eu\/es\/wp-json\/wp\/v2\/success-stories\/2821","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/evolutioneurope.eu\/es\/wp-json\/wp\/v2\/success-stories"}],"about":[{"href":"https:\/\/evolutioneurope.eu\/es\/wp-json\/wp\/v2\/types\/success-stories"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/evolutioneurope.eu\/es\/wp-json\/wp\/v2\/media\/2458"}],"wp:attachment":[{"href":"https:\/\/evolutioneurope.eu\/es\/wp-json\/wp\/v2\/media?parent=2821"}],"wp:term":[{"taxonomy":"flags","embeddable":true,"href":"https:\/\/evolutioneurope.eu\/es\/wp-json\/wp\/v2\/flags?post=2821"},{"taxonomy":"program","embeddable":true,"href":"https:\/\/evolutioneurope.eu\/es\/wp-json\/wp\/v2\/program?post=2821"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/evolutioneurope.eu\/es\/wp-json\/wp\/v2\/sector?post=2821"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}